Drug Therapy in Adult Congenital Heart Disease

• Published in: Cardiac electrophysiology clinics Vol. 9; no. 2; pp. 295 - 309
• Main Authors: Contractor, Tahmeed, MD, Levin, Vadim, MD, Mandapati, Ravi, MD, FHRS, FACC
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-06-2017
• Subjects: Adult; Anti-Arrhythmia Agents - administration & dosage; Anti-Arrhythmia Agents - adverse effects; Anti-Arrhythmia Agents - therapeutic use; Anticoagulants - administration & dosage; Anticoagulants - adverse effects; Anticoagulants - therapeutic use; Anticoagulation; Arrhythmia; Arrhythmias, Cardiac - drug therapy; Cardiovascular; Congenital heart disease; Drug therapy; Heart Defects, Congenital - drug therapy; Humans; Anticoagulation; Congenital heart disease; Arrhythmia; Drug therapy
• ISSN: 1877-9182; 1877-9190
• DOI: 10.1016/j.ccep.2017.02.011

Adults with congenital heart disease are at risk for atrial and ventricular arrhythmias that can lead to an increased morbidity as well as mortality. When catheter ablation is not an option or unsuccessful, antiarrhythmic drugs are the mainstay of treatment. There is limited data on the use of antiarrhythmics in this population. The purpose of this article is to discuss the practical aspects of the use of antiarrhythmics in adults with congenital heart disease. Several tables have been provided to provide clinicians a reference for daily use.